Learning Objectives:
At the end of this activity, participants should be able to:
- Describe the indication of a select number of new drugs and vaccines approved in 2023 and 2024.
- Contrast key prescribing information such as the dosing, adverse events, storage, and drug interactions of these agents.
- Utilize the provided information to successfully impact patient care in his or her pharmacy practice setting.
Faculty: Erin DiMuzio, PharmD
The CE faculty, reviewers and planning committee members have all reported no relationships with ineligible companies in relation to this program.
Fees:
FREE for NPTA CE+/Elite Members.
$10 for NPTA Insiders/Non-members.
Purchases are non-refundable and non-transferrable.
Contact Hour(s): 2
Activity Type: Knowledge-Based
Target Audience: Certified Pharmacy Technicians & Pharmacists
ACPE UAN(s): 0384-0000-24-051-H01-T/P
Activity Format: On-Demand Home Study
Release Date: 04/29/2024
Planned Expiration Date: 04/29/2027
CPE Credit Requirements: To receive credit for this ON-DEMAND program, participants must complete the post-test with a passing score of 70%. Participants are given two opportunities to achieve a passing score and receive CPE credit.
System Technical Requirements:
CE activities are delivered via your web browser and/or Adobe Acrobat (PDF). View the minimum technical and system requirements for CE activities.
Support: For questions or support, email us at support@pharmacytechnician.org or call 888-247-8700
If you have questions regarding our privacy/confidentiality policies, please review our Privacy, Data and Terms of Use policy.
NPTA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
© NPTA. All rights reserved. These materials may not be used, in whole or in part, for any purposes, commercial or otherwise, without prior permission in writing from the copyright owner(s).